$27.9M to develop novel therapeutics options for patients with cancer
RI-MUHC is part of a Quebec-wide collaborative effort to provide oncology innovation and discovery pipeline
Patient empowerment app Opal wins Prix d'excellence honour
Technology and patient insight at the heart of innovative patient portal developed at the MUHC
Recognizing great ideas at the McGill Clinical Innovation Competition
Congratulations to two winning teams from the RI-MUHC: BetaSense and Antibiotic Sentinel!
Two RI-MUHC early-career researchers explore new frontiers
David Labbé and Géraldine Merle are in the inaugural cohort awarded funding from the New Frontiers in Research Fund from the Canadian government
Hope on the horizon for hard-to-treat breast cancers
Unique multi-party collaboration forged to develop new anti-cancer therapies targeting DNA repair regulators
Four RI-MUHC grad students land top federal funding
Four graduate students from the Research Institute of the McGill University Health Centre (RI-MUHC) are among the 16 from McGill to win 2019 Vanier Scholarships.
Harnessing the body’s power in fight against cancer
Immunotherapy has provided lung cancer patients with real hope of recovery
Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell
The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.
What’s new at the 2019 Cancer Research Program (CRP) Research Day?
Along with traditional presentations, the first CRP 3-minute thesis competition!
Predicting Breast Cancer Metastasis to the Lung and Liver with Biomarkers
RI-MUHC researcher Peter Siegel and research associate Sébastien Tabariès have identified a key component of breast cancer metastasis to the liver and lung